Nanoparticles naturally accumulate in the liver; this can be a major limitation to any therapy needing delivery to other organs or tissues. Here the authors review the reason for predominant liver uptake and explore different strategies used to target non-viral gene delivery nanoparticles to other organs and tissues.
- Jeonghwan Kim
- Yulia Eygeris
- Gaurav Sahay
